Loading...
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens. METHODS: This multicentre, randomized, open-lab...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3128271/ https://ncbi.nlm.nih.gov/pubmed/20574663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-010-0941-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|